Suppr超能文献

雌激素受体及雌激素受体信使核糖核酸在胃癌组织中的表达

Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues.

作者信息

Zhao Xin-Han, Gu Shan-Zhi, Liu Shan-Xi, Pan Bo-Rong

机构信息

Department of Medical Oncology, First Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi Province, China.

出版信息

World J Gastroenterol. 2003 Apr;9(4):665-9. doi: 10.3748/wjg.v9.i4.665.

Abstract

AIM

To study estrogen receptor (ER) and estrogen receptor messenger RNA (ERmRNA) expression in gastric carcinoma tissues and to investigate their association with the pathologic types of gastric carcinoma.

METHODS

The expression of ER and ERmRNA in gastric carcinoma tissues (15 males and 15 females, 42-70 years old) was detected by immunohistochemistry and in situ hybridization, respectively.

RESULTS

The positive rate of ER (immunohistochemistry) was 33.3 % in males and 46.7 % in females. In Borrmann IV gastric carcinoma ER positive rate was greater than that in other pathologic types, and in poorly differentiated adenocarcinoma and signet ring cell carcinoma the positive rates were greater than those in other histological types of both males and females (P<0.05). The ER was more highly expressed in diffused gastric carcinoma than in non-diffused gastric carcinoma (P<0.05). The ER positive rate was also related to regional lymph nodes metastases (P<0.05), and was significantly higher in females above 55 years old, and higher in males under 55 years old (P<0.05). The ERmRNA (in situ hybridization) positive rate was 73.3 % in males and 86.7 % in females. The ERmRNA positive rates were almost the same in Borrmann I, II, III and IV gastric carcinoma (P>0.05). ERmRNA was expressed in all tubular adenocarcinoma, poorly differentiated adenocarcinoma and signet ring cell carcinoma (P<0.05). The ERmRNA positive rate was related to both regional lymph nodes metastases and gastric carcinoma growth patterns, and was higher in both sexes above 55 years old but without statistical significance (P>0.05). The positive rate of ERmRNA expression by in situ hybridization was higher than that of ER expression by immunohistochemistry (P<0.05).

CONCLUSION

ERmRNA expression is related to the pathological behaviors of gastric carcinoma, which might help to predict the prognosis and predict the effectiveness of endocrine therapy for gastric carcinoma.

摘要

目的

研究雌激素受体(ER)及雌激素受体信使核糖核酸(ERmRNA)在胃癌组织中的表达情况,并探讨其与胃癌病理类型的关系。

方法

分别采用免疫组织化学和原位杂交方法检测胃癌组织(男性15例,女性15例,年龄42 - 70岁)中ER和ERmRNA的表达。

结果

ER(免疫组织化学)阳性率男性为33.3%,女性为46.7%。Borrmann Ⅳ型胃癌的ER阳性率高于其他病理类型,在低分化腺癌和印戒细胞癌中,男性和女性的阳性率均高于其他组织学类型(P<0.05)。弥漫型胃癌中ER的表达高于非弥漫型胃癌(P<0.05)。ER阳性率还与区域淋巴结转移有关(P<0.05),55岁以上女性显著高于55岁以下男性(P<0.05)。ERmRNA(原位杂交)阳性率男性为73.3%,女性为86.7%。Borrmann Ⅰ、Ⅱ、Ⅲ和Ⅳ型胃癌的ERmRNA阳性率几乎相同(P>0.05)。ERmRNA在所有管状腺癌、低分化腺癌和印戒细胞癌中均有表达(P<0.05)。ERmRNA阳性率与区域淋巴结转移及胃癌生长方式有关,55岁以上男女阳性率均较高,但无统计学意义(P>0.05)。原位杂交检测的ERmRNA表达阳性率高于免疫组织化学检测的ER表达阳性率(P<0.05)。

结论

ERmRNA表达与胃癌的病理行为有关,可能有助于预测胃癌预后及内分泌治疗效果。

相似文献

1
Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues.
World J Gastroenterol. 2003 Apr;9(4):665-9. doi: 10.3748/wjg.v9.i4.665.
2
The role of Reg IV gene and its encoding product in gastric carcinogenesis.
Hum Pathol. 2010 Jan;41(1):59-69. doi: 10.1016/j.humpath.2009.06.013. Epub 2009 Sep 8.
3
Estrogen receptor beta is expressed in human stomach adenocarcinoma.
J Cancer Res Clin Oncol. 2002 Jun;128(6):319-24. doi: 10.1007/s00432-002-0336-3. Epub 2002 Apr 11.
4
Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer.
Ann Surg Oncol. 2016 Dec;23(13):4344-4351. doi: 10.1245/s10434-016-5448-0. Epub 2016 Jul 28.
6
Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
World J Gastroenterol. 2004 Oct 15;10(20):3044-7. doi: 10.3748/wjg.v10.i20.3044.
8
Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
World J Gastroenterol. 2005 Nov 14;11(42):6601-6. doi: 10.3748/wjg.v11.i42.6601.

引用本文的文献

1
Supportive care of female hormones in brain health: what and how?
Front Pharmacol. 2024 Jul 24;15:1403969. doi: 10.3389/fphar.2024.1403969. eCollection 2024.
2
Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer.
Genes Dis. 2021 Aug 21;9(5):1269-1280. doi: 10.1016/j.gendis.2021.07.006. eCollection 2022 Sep.
3
Protective effects of female reproductive factors on gastric signet-ring cell carcinoma.
World J Clin Cases. 2022 Jun 6;10(16):5217-5229. doi: 10.12998/wjcc.v10.i16.5217.
4
Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women.
Gastric Cancer. 2022 Jan;25(1):11-21. doi: 10.1007/s10120-021-01241-1. Epub 2021 Sep 1.
5
Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Pathol Oncol Res. 2020 Jan;26(1):63-78. doi: 10.1007/s12253-018-00569-x. Epub 2019 Jan 8.
6
Prognostic impact of FOXF1 polymorphisms in gastric cancer patients.
Pharmacogenomics J. 2018 Apr;18(2):262-269. doi: 10.1038/tpj.2017.9. Epub 2017 Apr 11.
7
Sex differences and effects of oestrogen in rat gastric mucosal defence.
World J Gastroenterol. 2017 Jan 21;23(3):426-436. doi: 10.3748/wjg.v23.i3.426.
8
Estrogen receptors in gastric cancer: Advances and perspectives.
World J Gastroenterol. 2016 Feb 28;22(8):2475-82. doi: 10.3748/wjg.v22.i8.2475.
9
Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer.
Adv Biomed Res. 2015 Aug 31;4:177. doi: 10.4103/2277-9175.164013. eCollection 2015.
10
Clinicopathological features and trend changes of gastric carcinoma in Southern China.
World J Gastroenterol. 2014 Apr 21;20(15):4401-6. doi: 10.3748/wjg.v20.i15.4401.

本文引用的文献

3
Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer.
World J Gastroenterol. 2002 Aug;8(4):591-5. doi: 10.3748/wjg.v8.i4.591.
4
Expression of estrogen receptors alpha and beta in human lung tissue and cell lines.
Lung Cancer. 2002 Aug;37(2):153-9. doi: 10.1016/s0169-5002(02)00039-9.
7
Estrogen receptor beta is expressed in human stomach adenocarcinoma.
J Cancer Res Clin Oncol. 2002 Jun;128(6):319-24. doi: 10.1007/s00432-002-0336-3. Epub 2002 Apr 11.
10
Androgen and estrogen receptor mRNA status in apocrine carcinomas.
Diagn Mol Pathol. 2002 Jun;11(2):113-8. doi: 10.1097/00019606-200206000-00008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验